Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2024-07-29 Major Shareholding Noti…
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Updates
Major Shareholding Notification Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the reclassification of a shareholder entity from 'Promoter & Promoter Group' to 'Public' category. It references Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes a certified extract of the Board of Directors meeting minutes approving this reclassification. The content focuses on board approval and regulatory compliance related to shareholding classification, not on financial results, audit, or other report types. This fits the category of a regulatory announcement about shareholding classification changes, which aligns with Major Shareholding Notification (MRQ). The document length and detail confirm it is not a brief announcement but a formal notification of a significant shareholding status change.
2024-07-29 English
Allotment of Securities
Share Issue/Capital Change Classification · 100% confidence The document is a letter addressed to stock exchanges announcing the allotment of shares to employees under a stock option plan. It details the increase in paid-up share capital and the number of shares allotted. There is no financial data, report, or detailed analysis present. The document is an announcement regarding a change in the company's capital structure due to share allotment. According to the filing definitions, this fits the category of 'Share Issue/Capital Change' (SHA). The document length is short and it is not a report itself but an announcement of a capital change event.
2024-07-29 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated July 29, 2024, announcing the consolidated financial results for the quarter Q1FY25 ended June 30, 2024. It includes detailed financial highlights such as revenues, EBITDA, PAT, EPS, and growth metrics. The text also contains management commentary on performance and outlook, along with detailed investor communication and presentation slides. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content focuses on quarterly financial results with actual financial data and analysis, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an earnings release (ER) as it contains detailed financial tables and management discussion, nor is it a full Annual Report (10-K). Therefore, the appropriate classification is IR with high confidence.
2024-07-29 English
Financial Result Updates
Interim / Quarterly Report Classification · 98% confidence The document is dated July 29, 2024, and is addressed to stock exchanges in India, referencing compliance with SEBI Listing Regulations. It announces the outcome of a Board Meeting where the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2024, were approved. The document includes a Limited Review Report by the statutory auditors, which is a standard procedure for interim financial results in India. The presence of detailed financial data for the quarter, including revenues, expenses, and profit/loss figures, confirms this is a financial report for a period shorter than a full fiscal year. The document is about quarterly unaudited financial results and includes substantive financial data and auditor review, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification, but contains actual financial statements and analysis for the quarter ended June 30, 2024.
2024-07-29 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an official notification addressed to stock exchanges regarding the incorporation of a step-down wholly owned subsidiary in New Zealand by Strides Pharma Global Pte. Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is focused on informing the market about a corporate event (subsidiary incorporation) rather than providing financial results, management discussion, or detailed reports. There are no financial statements or earnings data, nor is this a report or presentation. This fits the category of a Capital/Financing Update (CAP) as it relates to corporate structure and capital changes through subsidiary incorporation.
2024-07-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss or misplacement by shareholders. It includes details of shareholders, certificate numbers, and correspondence with the registrar and transfer agent (RTA). There is no financial data, earnings information, management discussion, or regulatory filing of financial results. The document is an announcement related to share certificates and shareholder records, specifically about lost certificates and the process for issuing duplicates. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related disclosure under SEBI regulations but does not fit into more specific categories like share issue, director dealings, or capital updates. The document length is moderate and contains detailed information, not just a brief notice or report publication announcement. Therefore, the best classification is Regulatory Filings (RNS).
2024-07-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.